rs149825190

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_000154.2(GALK1):​c.746C>T​(p.Ala249Val) variant causes a missense change. The variant allele was found at a frequency of 0.000574 in 1,613,720 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A249T) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00064 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00057 ( 2 hom. )

Consequence

GALK1
NM_000154.2 missense

Scores

2
17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:3

Conservation

PhyloP100: 3.68

Publications

7 publications found
Variant links:
Genes affected
GALK1 (HGNC:4118): (galactokinase 1) Galactokinase is a major enzyme for the metabolism of galactose and its deficiency causes congenital cataracts during infancy and presenile cataracts in the adult population. [provided by RefSeq, Jul 2008]
GALK1 Gene-Disease associations (from GenCC):
  • galactokinase deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Myriad Women’s Health, Labcorp Genetics (formerly Invitae), G2P, Orphanet, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.014584869).
BP6
Variant 17-75762751-G-A is Benign according to our data. Variant chr17-75762751-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 325232.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.000644 (98/152158) while in subpopulation AMR AF = 0.00242 (37/15274). AF 95% confidence interval is 0.00181. There are 0 homozygotes in GnomAd4. There are 48 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GALK1NM_000154.2 linkc.746C>T p.Ala249Val missense_variant Exon 5 of 8 ENST00000588479.6 NP_000145.1 P51570V9HWE7
GALK1NM_001381985.1 linkc.746C>T p.Ala249Val missense_variant Exon 5 of 9 NP_001368914.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GALK1ENST00000588479.6 linkc.746C>T p.Ala249Val missense_variant Exon 5 of 8 1 NM_000154.2 ENSP00000465930.1 P51570

Frequencies

GnomAD3 genomes
AF:
0.000644
AC:
98
AN:
152158
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00242
Gnomad ASJ
AF:
0.00576
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000942
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000470
Gnomad OTH
AF:
0.00144
GnomAD2 exomes
AF:
0.000737
AC:
185
AN:
251030
AF XY:
0.000663
show subpopulations
Gnomad AFR exome
AF:
0.0000617
Gnomad AMR exome
AF:
0.00171
Gnomad ASJ exome
AF:
0.00467
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.0000924
Gnomad NFE exome
AF:
0.000573
Gnomad OTH exome
AF:
0.00163
GnomAD4 exome
AF:
0.000567
AC:
828
AN:
1461562
Hom.:
2
Cov.:
32
AF XY:
0.000519
AC XY:
377
AN XY:
727096
show subpopulations
African (AFR)
AF:
0.000119
AC:
4
AN:
33480
American (AMR)
AF:
0.00210
AC:
94
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00455
AC:
119
AN:
26136
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39700
South Asian (SAS)
AF:
0.0000232
AC:
2
AN:
86258
European-Finnish (FIN)
AF:
0.000151
AC:
8
AN:
53112
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5764
European-Non Finnish (NFE)
AF:
0.000492
AC:
547
AN:
1112000
Other (OTH)
AF:
0.000844
AC:
51
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
52
105
157
210
262
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000644
AC:
98
AN:
152158
Hom.:
0
Cov.:
32
AF XY:
0.000646
AC XY:
48
AN XY:
74330
show subpopulations
African (AFR)
AF:
0.000121
AC:
5
AN:
41424
American (AMR)
AF:
0.00242
AC:
37
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.00576
AC:
20
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5196
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.0000942
AC:
1
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000470
AC:
32
AN:
68034
Other (OTH)
AF:
0.00144
AC:
3
AN:
2088
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
5
10
15
20
25
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000652
Hom.:
0
Bravo
AF:
0.000669
TwinsUK
AF:
0.00135
AC:
5
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00116
AC:
10
ExAC
AF:
0.000560
AC:
68
EpiCase
AF:
0.000382
EpiControl
AF:
0.000711

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Deficiency of galactokinase Uncertain:2Benign:2
Nov 11, 2019
Natera, Inc.
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

Apr 03, 2019
Revvity Omics, Revvity
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

GALK1-related disorder Benign:1
Feb 28, 2022
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.080
BayesDel_addAF
Benign
-0.40
T
BayesDel_noAF
Benign
-0.36
CADD
Benign
22
DANN
Benign
0.74
DEOGEN2
Benign
0.25
T;.;T
Eigen
Benign
-0.16
Eigen_PC
Benign
-0.073
FATHMM_MKL
Uncertain
0.91
D
LIST_S2
Uncertain
0.96
.;D;D
M_CAP
Benign
0.050
D
MetaRNN
Benign
0.015
T;T;T
MetaSVM
Benign
-0.50
T
MutationAssessor
Benign
0.99
L;.;L
PhyloP100
3.7
PrimateAI
Benign
0.44
T
PROVEAN
Benign
0.82
N;.;.
REVEL
Benign
0.21
Sift
Benign
1.0
T;.;.
Sift4G
Benign
0.51
T;T;T
Polyphen
0.50
P;.;P
Vest4
0.27
MVP
0.86
MPC
0.16
ClinPred
0.036
T
GERP RS
4.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.15
gMVP
0.22
Mutation Taster
=72/28
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs149825190; hg19: chr17-73758832; COSMIC: COSV99045309; COSMIC: COSV99045309; API